Senior Director of Manufacturing for cell and gene therapy in the U.S., Maggie Chen, discusses supply chain challenges, the promise of standardized viral vector platforms, the future of analytics, development and manufacturing challenges, and the future of the cell and gene therapy industry.
With two global sites offering full-scale cell and gene services backed by 30 years of science, our network offers expertise that no other CDMO can offer today.